Rani Therapeutics Holdings (RANI) Return on Capital Employed (2021 - 2025)
Historic Return on Capital Employed for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q3 2025 value amounting to 7.95%.
- Rani Therapeutics Holdings' Return on Capital Employed rose 101600.0% to 7.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.95%, marking a year-over-year increase of 101600.0%. This contributed to the annual value of 1.95% for FY2024, which is 10700.0% down from last year.
- According to the latest figures from Q3 2025, Rani Therapeutics Holdings' Return on Capital Employed is 7.95%, which was up 101600.0% from 441.93% recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Return on Capital Employed ranged from a high of 441.93% in Q2 2025 and a low of 5.0% during Q1 2025
- Over the past 5 years, Rani Therapeutics Holdings' median Return on Capital Employed value was 0.68% (recorded in 2023), while the average stood at 25.28%.
- The largest annual percentage gain for Rani Therapeutics Holdings' Return on Capital Employed in the last 5 years was 4437300bps (2025), contrasted with its biggest fall of -35000bps (2025).
- Quarter analysis of 5 years shows Rani Therapeutics Holdings' Return on Capital Employed stood at 0.4% in 2021, then plummeted by -52bps to 0.61% in 2022, then tumbled by -92bps to 1.18% in 2023, then plummeted by -124bps to 2.64% in 2024, then soared by 401bps to 7.95% in 2025.
- Its Return on Capital Employed stands at 7.95% for Q3 2025, versus 441.93% for Q2 2025 and 5.0% for Q1 2025.